Drug Type Small molecule drug |
Synonyms NA 921, NA921 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rett Syndrome | Phase 3 | US | 15 Jun 2025 | |
Rett Syndrome | Phase 3 | AU | 15 Jun 2025 | |
Fragile X Syndrome | Phase 3 | US | - |